igf-1 lr3 more plates more dates Recombinant Human LR3-IGF-1(E51R) Protein IGF-1 LR3 vs GH Peptides
Description
CD20, a specific surface marker of B cells, is the target of anti-CD20 monoclonal antibodies (e.g., ocrelizumab, ofatumumab, rituximab, ublituximab)
10.1016/j.micres.2016.12.003 Microbiol
Ha, H.-J
45 min pre-treatment and 6 h post-treatment) in accordance with the American Thoracic Society/European Respiratory Society (ATS/ERS) 2005 guidelines [25]
